Mosley, Nathaniel
Chung, Joon Y.
Jin, Gina
Franceschini, Maria A.
Whalen, Michael J.
Chung, David Y. http://orcid.org/0000-0002-7149-5851
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R25NS065743, K08NS112601)
American Heart Association (18POST34030369)
National Center for Advancing Translational Sciences (KL2TR002542)
Article History
Received: 12 August 2021
Accepted: 15 February 2022
First Online: 4 April 2022
Conflicts of Interest
: MAF has a financial interest in 149 Medical, Inc., a company developing DCS technology for assessing and monitoring cerebral blood flow in newborn infants. MAF’s interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham in accordance with their conflict of interest policies. The remaining authors state no conflict of interests.
: Ethical approvals through the Institutional Animal Care and Use Committee (IACUC) for animal studies were obtained as stated in the article.